If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Best Practice Database
Medical Affairs » Medical Science Liaison
Download FREE Excerpt
8 Info Graphics
10 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
The involvement of medical science liaisons (MSLs) in the development and execution of Phase IV studies is particularly important, considering that Phase IV is a critical means to generate real world data that serves the needs of vital stakeholders such as payers and regulatory bodies.
As a result, pharmaceutical and biotech companies are driving their efforts toward maximizing the impact of MSLs on Phase IV studies.
Best Practices, LLC conducted this benchmarking research to probe how leading pharmaceutical and biotech organizations are raising Phase IV performance and value through optimal involvement of MSLs. This study characterizes the MSL contributions most essential to Phase IV and delivers benchmarks around the field team structures that help maximize MSL impact on Phase IV studies.
Best Practices, LLC engaged 43 Medical Affairs leaders from 31 pharmaceutical and biotechnology companies in this research through a benchmarking survey and interviews.
If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.